Novo Nordisk's pricing tactics within the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who has accused the company of rate gouging, declaring the stark contrast among U.S. rates and people in Europe and copyright.California biotech behemoth Amgen ditched strategies for an experimental weight loss pill in May but continues to